Discovery of Novel Protein Biomarkers in Urine for Diagnosis of Urothelial Cancer Using iTRAQ Proteomics-Reference-Cited by-同舟云学术

Discovery of Novel Protein Biomarkers in Urine for Diagnosis of Urothelial Cancer Using iTRAQ Proteomics

Published:2021-03-29 Issue:5 Volume:20 Page:2953-2963
ISSN:1535-3893
Container-title:Journal of Proteome Research
language:en
Short-container-title:J. Proteome Res.

Author:

Chen Chao-Jung¹²,Chou Che-Yi³⁴⁵,Shu Kuo-Hsiung⁶,Chen Hung-Chun⁷,Wang Ming-Cheng⁸,Chang Chia-Chu⁹,Hsu Bang-Gee¹⁰,Wu Mai-Szu¹¹,Yang Yuan-Lung¹²,Liao Wen-Ling¹¹³,Yang Chieh¹⁴,Hsiao Yu-Tien¹⁴,Huang Chiu-Ching¹⁴

Affiliation:

1. Graduate Institute of Integrated Medicine, China Medical University, Taichung 404333, Taiwan

2. Proteomics Core Laboratory, Department of Medical Research, China Medical University Hospital, Taichung 404332, Taiwan

3. Department of Internal Medicine, Asia University Hospital, Taichung 41354, Taiwan

4. Department of Post-baccalaureate Veterinary Medicine, Asia University, Taichung, Taiwan

5. Division of Nephrology, China Medical University Hospital, Taichung 404332, Taiwan

6. Division of Nephrology, Lin Shin Hospital, Taichung 40867, Taiwan

7. Division of Nephrology, Kaohsiung Medical University and Hospitals, Kaohsiung 80708, Taiwan

8. Division of Nephrology, Cheng Kung University Hospital, Tainan 70403, Taiwan

9. Department of Internal Medicine, Kuang Tien General Hospital, Taichung 43303, Taiwan

10. Division of Nephrology, Buddhist Tzu Chi General Hospital, Hualien 43303, Taiwan

11. Division of Nephrology, Taipei Medical University and Hospitals, Taipei 110, Taiwan

12. Division of Urology, St. Mary’s Hospital, Yilan 26546, Taiwan

13. Center for Personalized Medicine, China Medical University Hospital, Taichung 404332, Taiwan

14. Division of Nephrology and the Kidney Institute, Department of Internal Medicine, China Medical University and Hospitals, Taichung 404332, Taiwan

Funder

Academia Sinica

Ministry of Science and Technology, Taiwan

Publisher

American Chemical Society (ACS)

Subject

General Chemistry,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jproteome.1c00164

Reference53 articles.

1. The present and future burden of urinary bladder cancer in the world

2. Combinational treatment of all‐trans retinoic acid (ATRA) and bisdemethoxycurcumin (BDMC)‐induced apoptosis in liver cancer Hep3B cells

3. MULTIVARIATE ANALYSIS OF CLINICAL PARAMETERS OF SYNCHRONOUS PRIMARY SUPERFICIAL BLADDER CANCER AND UPPER URINARY TRACT TUMOR

4. Differences Between Local and Review Urinary Cytology in Diagnosis of Bladder Cancer. An Interobserver Multicenter Analysis

5. COST-EFFECTIVENESS OF A MODIFIED CARE PROTOCOL SUBSTITUTING BLADDER TUMOR MARKERS FOR CYSTOSCOPY FOR THE FOLLOWUP OF PATIENTS WITH TRANSITIONAL CELL CARCINOMA OF THE BLADDER: A DECISION ANALYTICAL APPROACH

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fraisinib: a calixpyrrole derivative reducing A549 cell-derived NSCLC tumor in vivo acts as a ligand of the glycine-tRNA synthase, a new molecular target in oncology;Frontiers in Pharmacology;2024-01-03

2. Identification of common genes and pathways underlying imatinib and nilotinib treatment in CML: a Bioinformatics Study;Nucleosides, Nucleotides & Nucleic Acids;2023-12-20

3. CHRISTMAS: Chiral Pair Isobaric Labeling Strategy for Multiplexed Absolute Quantitation of Enantiomeric Amino Acids;Analytical Chemistry;2023-11-30

4. Elucidating the Mechanisms of Sodium Benzoate in Alzheimer Disease: Insights from Quantitative Proteomics Analysis of Serum Samples;International Journal of Neuropsychopharmacology;2023-10-24

5. Liquid biopsy in urothelial carcinoma: Detection techniques and clinical applications;Biomedicine & Pharmacotherapy;2023-09